Malyszko Jolanta, Malyszko Jacek S, Hryszko Tomasz, Brzosko Szymon, Lebkowska Urszula, Mysliwiec Michal
Department of Nephrology, Medical University, Bialystok, Poland.
Transpl Int. 2005 Feb;18(2):256-9. doi: 10.1111/j.1432-2277.2004.00027.x.
Cardiovascular disease (CVD) is the main cause of mortality and morbidity among kidney transplant recipients (Tx). Intima-media thickness (IMT) of the common carotid artery is related to CVD. Hemostatic disturbances may contribute to the CVD pathogenesis in Tx. The aim of the study was to evaluate some hemostatic factors in Tx with and without coronary artery disease (CAD) and their correlations with IMT. Patients with CAD were significantly older, with thicker IMT, lower plasmin-antiplasmin complexes (PAP), higher fibrinogen, cholesterol, triglycerides, Thrombin-activatable fibrinolysis inhibitor (TAFI) antigen and activity, prolonged euglobulin clot lysis time when compared to those without CAD. Kidney transplant recipients have higher mean blood pressure, serum lipids, fibrinogen, TAFI antigen, TAFI activity, markers of coagulation and fibrinolysis, thicker IMT and lower PAP relative to healthy volunteers. In univariate analysis, IMT correlated significantly with age, time on dialysis prior to transplantation, PAP, fibrinogen, hematocrit, body mass index (BMI). Multiple regression analysis showed that only age, hematocrit, PAP, and time on dialysis prior to transplantation were positive independent predictors of IMT. Hypofibrinolysis may contribute to the arterial remodeling in Tx. Dialysis therapy before transplantation makes detrimental changes in arterial vasculature.
心血管疾病(CVD)是肾移植受者(Tx)死亡和发病的主要原因。颈总动脉内膜中层厚度(IMT)与心血管疾病相关。止血功能紊乱可能在肾移植受者心血管疾病发病机制中起作用。本研究的目的是评估有和没有冠状动脉疾病(CAD)的肾移植受者的一些止血因子及其与IMT的相关性。与没有CAD的患者相比,患有CAD的患者年龄显著更大,IMT更厚,纤溶酶 - 抗纤溶酶复合物(PAP)更低,纤维蛋白原、胆固醇、甘油三酯、凝血酶激活的纤维蛋白溶解抑制剂(TAFI)抗原和活性更高,优球蛋白凝块溶解时间延长。相对于健康志愿者,肾移植受者平均血压、血脂、纤维蛋白原、TAFI抗原、TAFI活性、凝血和纤维蛋白溶解标志物更高,IMT更厚,PAP更低。在单变量分析中,IMT与年龄、移植前透析时间、PAP、纤维蛋白原、血细胞比容、体重指数(BMI)显著相关。多元回归分析表明,只有年龄、血细胞比容、PAP和移植前透析时间是IMT的正向独立预测因子。纤维蛋白溶解功能减退可能导致肾移植受者的动脉重塑。移植前的透析治疗会使动脉血管系统发生有害变化。